| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 | Cell Death and Differentiation | 2018 | 2.2K |
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis | Journal of the National Cancer Institute | 2006 | 1.5K |
| Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma | British Journal of Haematology | 2008 | 1.4K |
| DNA repair pathways as targets for cancer therapy | Nature Reviews Cancer | 2008 | 1.2K |
| Histone recognition and large-scale structural analysis of the human bromodomain family | Cell | 2012 | 1.1K |
| Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up | Lancet, The | 2014 | 910 |
| Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse | Journal of Clinical Oncology | 2006 | 841 |
| ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response | Molecular Cell | 2017 | 800 |
| Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer | Lancet, The | 1992 | 724 |
| COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study | Lancet, The | 2020 | 586 |
| Long-term risk of cardiovascular disease in 10-year survivors of breast cancer | Journal of the National Cancer Institute | 2007 | 574 |
| Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial | Lancet, The | 2014 | 570 |
| hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer | Clinical Cancer Research | 2008 | 555 |
| Antiangiogenic therapy in oncology: current status and future directions | Lancet, The | 2016 | 507 |
| The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings | Molecular Oncology | 2011 | 492 |
| Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization | Nature Medicine | 2011 | 486 |
| Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials | Antioxidants and Redox Signaling | 2008 | 482 |
| DNA double-strand break repair: from mechanistic understanding to cancer treatment | DNA Repair | 2007 | 478 |
| A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth | PLoS ONE | 2009 | 475 |
| The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population | British Journal of Cancer | 2005 | 443 |
| Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress | Cancer Cell | 2015 | 421 |
| Guidelines for the management of oesophageal and gastric cancer | Gut | 2011 | 404 |
| Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies | Clinical Cancer Research | 2014 | 379 |
| Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis | Journal of Pathology | 1995 | 369 |
